CDKL3 anticorps (AA 51-150) (AbBy Fluor® 350)
-
- Antigène Voir toutes CDKL3 Anticorps
- CDKL3 (Cyclin-Dependent Kinase-Like 3 (CDKL3))
-
Épitope
- AA 51-150
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CDKL3 est conjugé à/à la AbBy Fluor® 350
-
Application
- Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunofluorescence (Cultured Cells) (IF (cc))
- Homologie
- Human,Mouse,Rat,Dog,Cow,Sheep,Horse,Rabbit
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from human CDKL3/NKIAMRE
- Isotype
- IgG
- Top Product
- Discover our top product CDKL3 Anticorps primaire
-
-
- Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Date de péremption
- 12 months
-
- Antigène
- CDKL3 (Cyclin-Dependent Kinase-Like 3 (CDKL3))
- Autre désignation
- CDKL3 (CDKL3 Produits)
- Synonymes
- anticorps NKIAMRE, anticorps Nkiatre, anticorps Nkiatreb, anticorps AI852479, anticorps B230379H01Rik, anticorps CDKL3, anticorps cyclin dependent kinase like 3, anticorps cyclin-dependent kinase-like 3, anticorps CDKL3, anticorps Cdkl3
- Sujet
-
Synonyms: CDKL3 protein, Cyclin dependent kinase like 3, CDKL3_HUMAN.
Background: A novel cyclin-dependent kinase-related molecule, NKIAMRE, has been identified that is thought to be a tumor suppressor locus. The NKIAMRE gene is located on chromosome 5q, a region that is often deleted in human acute leukemia and human myeloid dysplastic disorders.
- ID gène
- 51265
- Pathways
- Cycle Cellulaire
-